MTNB - PRICE - Matinas BioPharma

This daily price chart for Matinas BioPharma (MTNB) on the GURU.Markets platform is currently at 0.16. Matinas BioPharma is developing an innovative lipid crystal system for drug delivery, protecting its business with patents for licensing. Growth is driven by partnerships with industry behemoths and tests of oral amphotericin B. Current preclinical successes are providing a muted effect while the market awaits full-scale late-stage trials.

By fully outsourcing clinical trials and lipid nanoparticle development to third-party contractors, Matinas BioPharma (MTNB) minimizes operational risks, which directly impacts the market value of its shares. This line chart captures the asset's current price, allowing investors to assess business resilience to shocks through drawdown analysis and timely identify anomalies that precede changes in financial performance.